Related Experiment Videos
Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells
Endocrinology
|April 1, 1984
Summary
Vasoactive intestinal peptide (VIP) activates cAMP signaling in human osteosarcoma cells (SaOs-2) by binding to specific receptors. These cells offer a model for studying VIP
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Vasoactive intestinal peptide (VIP) is known to stimulate bone resorption.
- The precise cellular mechanisms and receptors involved in VIP's action on bone cells require further elucidation.
Purpose of the Study:
- To characterize functional vasoactive intestinal peptide (VIP) receptors on SaOs-2 human osteosarcoma cells.
- To investigate the signaling pathways and cellular responses mediated by VIP in these cells.
- To establish SaOs-2 cells as a model for studying VIP's initial actions in bone.
Main Methods:
- Utilized SaOs-2 cells, a human osteosarcoma cell line.
- Measured cyclic AMP (cAMP) production in response to VIP and prostaglandin E2 (PGE2).
- Performed radioligand binding assays with [125I]VIP and Scatchard analysis.
- Investigated receptor desensitization through pre-treatment experiments.
- Assessed the effect of indomethacin on VIP-induced cAMP increases.
Main Results:
- SaOs-2 cells exhibit rapid, dose-dependent increases in cAMP upon VIP stimulation, mediated by specific high- and low-affinity receptors.
- VIP-induced cAMP signaling is independent of prostaglandin E2 (PGE2) production and cyclooxygenase activity.
- Cells displayed homologous desensitization to VIP and PGE2 upon pre-treatment, mirroring responses in intact bone.
- [125I]VIP binding revealed approximately 8,500 high-affinity (Kd=0.44 nM) and 57,000 low-affinity (Kd=17 nM) receptors per cell.
- VIP binding was partially inhibited by secretin and PHI-27, but not by PTH or calcitonin.
Conclusions:
- SaOs-2 cells possess functional VIP receptors that mediate cAMP increases, independent of PGE2.
- These cells provide a valuable in vitro model for investigating the initial molecular events of VIP action on bone cells.
- The observed cellular responses and receptor characteristics closely resemble those in intact bone, supporting their utility in bone biology research.